GeneDx

GeneDx, Inc., established in 2000 and publicly traded under NASDAQ:WGS, is a commercial-stage genomic diagnostics company. Headquartered in Stamford, Connecticut, with laboratory operations in Gaithersburg, Maryland, GeneDx specializes in advanced genetic testing for the diagnosis of rare and inherited disorders. The company offers a comprehensive suite of services, including whole exome sequencing, whole genome sequencing, and targeted gene panels, providing critical diagnostic insights to healthcare providers and hospitals. Its extensive product catalog supports personalized medicine and treatment planning.

A key differentiator for GeneDx is its operation of one of the world's largest rare disease genomic datasets. This vast repository of genetic information not only powers its sophisticated clinical testing capabilities but also serves as a valuable resource for drug discovery initiatives and health system research. The company's commitment to accessibility is further demonstrated through its provision of genetic counseling services and financial assistance programs, aiming to ensure broader patient access to essential diagnostic testing. Learn about GeneDx's global headquarters for detailed location information.

Operating within a competitive landscape that includes companies like Myriad Genetics and Illumina, GeneDx leverages its unique data assets and technical expertise. The company's scale is indicated by its employee range of 1,000-5,000 individuals and a revenue of $442.7M. GeneDx is dedicated to advancing genomic medicine through its diagnostic solutions and research collaborations. Meet GeneDx's team to understand the expertise driving its innovation in rare disease diagnostics and genomic data utilization.